Australia markets closed

Legend Biotech Corporation (LEGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.41-0.52 (-1.13%)
At close: 04:00PM EDT
45.42 +0.01 (+0.02%)
After hours: 05:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close45.93
Open46.33
Bid45.40 x 200
Ask45.46 x 200
Day's range45.25 - 46.81
52-week range42.08 - 77.32
Volume679,855
Avg. volume1,000,611
Market cap8.261B
Beta (5Y monthly)0.01
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma

    Following the label expansion, J&J's (JNJ) Carvykti is approved as a second-line treatment for adults with relapsed/refractory myeloma. It was initially approved for use as a fifth- or later-line treatment.

  • Zacks

    Why Legend Biotech (LEGN) Stock Might be a Great Pick

    Legend Biotech (LEGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

  • Insider Monkey

    Should You Continue to Hold Legend Biotech Corporation (LEGN)?

    Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. Optimism started to prevail, during the last months of the year, and investors reacted positively to news of a potential change in direction by the US Federal Reserve, as well as […]